These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase. Motulsky HJ, Shattil SJ, Ferry N, Rozansky D, Insel PA. Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346 [Abstract] [Full Text] [Related]
5. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding. Paris H, Galitzky J, Senard JM. Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632 [Abstract] [Full Text] [Related]
6. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry. Neubig RR, Gantzos RD, Brasier RS. Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672 [Abstract] [Full Text] [Related]
10. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition. Alexander RW, Cooper B, Handin RI. J Clin Invest; 1978 May; 61(5):1136-44. PubMed ID: 207726 [Abstract] [Full Text] [Related]
13. Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine. Jakobs KH, Saur W, Schultz G. J Cyclic Nucleotide Res; 1976 May; 2(6):381-92. PubMed ID: 14175 [Abstract] [Full Text] [Related]
14. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase. Turner JT, Ray-Prenger C, Bylund DB. Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671 [Abstract] [Full Text] [Related]
15. Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine. McKernan RM, Strickland WR, Insel PA. Mol Pharmacol; 1988 Jan; 33(1):51-7. PubMed ID: 2826999 [Abstract] [Full Text] [Related]
16. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor. Lanier SM, Hess HJ, Grodski A, Graham RM, Homcy CJ. Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829 [Abstract] [Full Text] [Related]
17. Alpha 2-adrenergic receptors on canine platelet membranes characterized by [3H]-yohimbine binding. O'Hara N, Yokota S, Kouchi Y, Ono H. Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):179-94. PubMed ID: 3012728 [Abstract] [Full Text] [Related]
18. Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosa. Valet P, Senard JM, Devedjian JC, Planat V, Salomon R, Voisin T, Drean G, Couvineau A, Daviaud D, Denis C. J Clin Invest; 1993 May; 91(5):2049-57. PubMed ID: 8098045 [Abstract] [Full Text] [Related]
19. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens. Minneman KP, Abel PW. Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249 [Abstract] [Full Text] [Related]
20. Species differences in alpha 2-adrenergic regulation of platelet adenylate cyclase. Slotkin TA, McCook EC, Nemeroff CB, Seidler FJ. Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):259-71. PubMed ID: 1658886 [Abstract] [Full Text] [Related] Page: [Next] [New Search]